Introduction {#s1}
============

The development of the human cerebral cortex is complex and requires precise regulation of neuronal proliferation, migration, and postmigrational development. Nodules of immature neurons in the germinal zone, referred to as periventricular nodular heterotopias, are likely caused by disruption of the neuroependyma, leading to defective radial glia and impaired neuronal migration ([@B5]). More recently, abnormal morphology of neuronal progenitor cells and defective migration have been reported in organoids as underlying cause of periventricular nodular heterotopia (PNH) ([@B7]). Polymicrogyria, an excessive number of small gyri, is thought to be caused by defects in the pia membrane and in postmigrational neuronal differentiation ([@B1]).

NEDD4L is a HECT E3 ubiquitin ligase with multiple substrates regulating, among others, neuronal functions ([@B3]; [@B12]; [@B11]). NEDD4L is highly expressed in the cortical plate, the ventricular zone, and the ganglionic eminences in the fetal brain of mice ([@B2]).

Recently, NEDD4L missense variants were identified in nine patients with periventricular nodular heterotopia (PNH), polymicrogyria (PMG), and variable features comprising 2-3 syndactyly of the toes, cleft palate, and epilepsy ([@B2]; [@B6]; [@B4]). All variants affected the HECT domain causing deregulation of the AKT/mTOR and TGF-ß/Smad2/3 signaling pathways ([@B2]; [@B6]). Four patients carried a recurrent mutation at p.(Glu893Lys) ([@B2]; [@B6]) and two variants at p.679 but with different substitutions have been reported ([@B2]; [@B4]), suggesting mutational hotspots. While six pathogenic variants occurred *de novo*, parental mosaicism accounts for three reported cases ([@B2]; [@B4]).

We report the first familial occurrence of a novel NEDD4L variant affecting the WW domain. The same variant occurred *de novo* in an additional case with a similar phenotype, suggesting a second mutational hotspot.

Methods {#s2}
=======

After obtaining written parental consent, Sanger sequencing of all coding regions and part of the introns of the NEDD4L gene (NM_001144967.2) was performed in two families of Caucasian origin. Additionally, written parental consent was obtained for the publication of clinical and molecular data. This study has been approved by the ethical committee of UZ Brussel. DNA samples from all patients and parents were derived from peripheral blood. DNA extraction was performed using standard procedures in the referring center. PCR and Sanger sequencing were performed using standard conditions. Primer sequences are available in [**Supplementary Data**](#SM1){ref-type="supplementary-material"}. For the index cases, all coding regions of the NEDD4L gene were tested. Parents and sibs have only been analyzed for the detected variant. The interpretation of sequencing data is performed with Sequence Pilot (JSI). Paternity analysis in family 1 has been performed and confirmed using Complete V2 (Devyser).

Case Reports {#s3}
============

Case 1 {#s3_1}
------

The proband was born after a normal pregnancy and delivery with birth weight of 4,100 gram and height of 51 cm. The mother was treated for infantile seizures up to the age of 4 years, the father had a single febrile convulsion. Clinical examination revealed macrocephaly (SDS +2), prominent forehead, bilateral clinodactyly of the 5th fingers, partial cutaneous 2-3 syndactyly of the toes ([**Figure 1A**](#f1){ref-type="fig"}), and penoscrotal hypospadias with bifid chordee. At the age of 20 months, mental age corresponded with 18 months and motor development with 14 months. He had febrile convulsions at the age of 20 months followed by focal seizures evolving to bilateral generalized convulsions for which he was treated for 2 years. At age 13 years, he is seizure free without medication. Brain MRI at age 14 months revealed bilateral PNH with overlying bilateral perisylvian PMG ([**Figures 1E--H**](#f1){ref-type="fig"}). Brain MRI of both parents was normal.

![Syndactyly phenotypes and brain MRI. **(A D)** indicate the presence of variable syndactyly in case 1 **(A)**, case 2 **(B, C)**, and the mother of case 2 **(D)**. Brain MRIs of case 1 **(E--H)** and case 2 **(I--L)**. Mild ventricular dilatation, bilateral PNH, and bilateral PMG are demonstrated in both cases **(E-G, I-K)**. **(H**, **L)** demonstrate thinning of the corpus callosum with normal infratentorial findings.](fgene-11-00026-g001){#f1}

Case 2 {#s3_2}
------

The proband was born after normal pregnancy and delivery with birth weight of 2,754 gram. He had neonatal convulsions at age 14 days and status epilepticus at age 6 weeks. Seizures are very refractory to treatment, with frequent intensive care admissions for status epilepticus. Despite various antiepileptic treatment regimens, at the age of 4 he still suffers from clusters of focal and secondary generalized seizures. At the age of 23 months mental age corresponded with 9.5 months and motor development with 5--6 months. Speech is absent. He has generalized hypotonia, a high forehead with normal head circumference (-0.5 SD), cutaneous right-sided 3-4 syndactyly and a left-sided 3-4-5 syndactyly of the fingers, and bilateral 2-3 syndactyly of the toes ([**Figures 1B, C**](#f1){ref-type="fig"}). Brain MRI revealed bilateral PNH with overlying perisylvian PMG ([**Figures 1I--L**](#f1){ref-type="fig"}).

The proband\'s mother had infantile febrile convulsions. She needed special education, as did the proband\'s maternal half-sister and half-brother. The half-siblings had no seizures. Both mother and half-sister showed 2-3 toe syndactyly ([**Figure 1D**](#f1){ref-type="fig"}). Brain MRI demonstrated PNH in all three.

Results {#s4}
=======

For both patients, a gene panel analysis was performed for "malformations of cortical development" (v3 of the panel, see <http://www.brightcore.be/mcd>) but no pathogenic variants were found. However, at the time of the investigation, NEDD4L was not included in this gene panel. Based on the clinical phenotype combining PNH, PMG, and syndactyly it was decided to perform targeted Sanger sequencing of the NEDD4L gene in a second phase.

In both families, a heterozygous c.623G \> A, p.(Arg208Gln) variant in exon 9 of NEDD4L was identified. While the previously reported NEDD4L variants all affected the HECT domain, the variant in our patients is located in the WW domain ([**Figure 2**](#f2){ref-type="fig"}). In Case 1, the variant was absent in both parents, indicating a *de novo* event. In Case 2, the variant was also identified in the affected mother and two half-siblings, segregating with the phenotype. The variant affects a highly conserved nucleotide (phyloP: 9.53) and amino acid and is absent in control databases (gnomAD, GoNl, dbSNP, ESP). Prediction programs PolyPhen2 and MutationTaster indicate a pathogenic effect (p value 1), while SIFT points to a polymorphism (score 0.05).

![Characteristics of the p.(Arg208Gln) variant. Sequence analysis shows a G \> A alteration at position 623 **(A)**. Location of the variant in the NEDD4L protein **(B)**; figure adapted from [@B6]. Conservation of the amino acid position up to C. elegans **(C)**; figure extracted from Alamut Visual (Version 2.11, Interactive Biosoftware).](fgene-11-00026-g002){#f2}

Discussion {#s5}
==========

Our findings together with a review of the published cases highlight the co-occurrence of PNH and PMG as core features of the NEDD4L imaging phenotype. Patient 1 shows penoscrotal hypospadia as a novel finding. Patient 2 presents with an extensive syndactyly, including an unusual pattern of syndactyly of the fingers ([**Figure 1C**](#f1){ref-type="fig"}). Our patients do not have cleft palate.

We describe the first familial occurrence, not associated with parental mosaicism, of a pathogenic variant in the NEDD4L gene with broad intra-familial phenotypic variability, varying from relatively well-functioning carriers with isolated PNH on brain MRI, to a severely affected case with profound developmental delay, refractory seizures, and PNH-PMG.

The NEDD4L variant in our patients affects the WW domain of the protein, while the previously reported variants were located in the HECT domain ([@B2]; [@B6]; [@B4]). WW domains can be found in different signaling proteins and contain two highly conserved tryptophan (W) residues. By forming monomeric protein binding modules *via* disulfide bridges, WW domains mediate protein-protein interactions. In NEDD4L, the WW domain is important for the recognition of substrates ([@B10]; [@B8]; [@B9]). We hypothesize that conformational changes cause a loss of function of the WW domain leading to impaired recognition of substrates and ultimately to loss of protein function. Similar to the previously reported c.2677G \> A, p.(Glu893Lys) variant in the NEDD4L HECT domain, the c.623G \> A, p.(Arg208Gln) variant in the WW domain represents another potential mutational hotspot. Although the affected domain differs, no major phenotypic differences can be appreciated.

In conclusion, this report highlights the importance of detailed review of the cerebral cortex in all patients with PNH. The combination of PNH and PMG should prompt for careful evaluation for syndactyly, clefts, and/or hypospadias since these findings are highly suggestive of NEDD4L-involvement.
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